Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewed
PAMD-Ch17, a Polymeric Analog of Plerixafor, Induces Mitochondrial Dysfunction in T-ALL Cells Independent of CXCR4
Calvin K. Lam, Arjun Dhir, Arnob Mitro…·R. Katherine Hyde
This paper shows PAMD-Ch17, a modified Plerixafor analog, kills T-ALL cells via mitochondrial dysfunction independent of CXCR4 inhibition.